Elasmogen is a precision biologics drug discovery company that develops soloMERs.
Elasmogen has raised $9.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2022.
Elasmogen's investors include Business Growth Fund, Scottish Enterprise, Innovate UK, Deepbridge Capital, Scottish National Investment Bank.
Elasmogen is headquartered in Aberdeen, United Kingdom.
Elasmogen is a precision biologics drug discovery company that develops soloMERs.
Elasmogen is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elasmogen — Funding & Investors." VCBacked, May 18, 2022, https://www.vcbacked.co/company/elasmogen. Accessed November 12, 2026.
VCBacked. (2022). Elasmogen — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/elasmogen
{{cite web |title=Elasmogen — Funding & Investors |url=https://www.vcbacked.co/company/elasmogen |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Elasmogen? Request a listing update